The risk of cardiovascular disease in prostate cancer patients receiving androgen deprivation therapies.

BACKGROUND: Androgen deprivation therapy (ADT), with a proven role in prostate cancer management, has been associated with various cardiovascular diseases. However, few studies have investigated these associations by type of ADT, particularly for newer ADTs such as the gonadotropin-releasing hormone...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Epidemiology
Asıl Yazarlar: Cardwell, Chris R., O’Sullivan, Joe M., Jain, Suneil, Harbinson, Mark T., Cook, Michael B., Hicks, Blánaid M., Menamin, Úna C. Mc
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2020
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7138701/
https://ncbi.nlm.nih.gov/pubmed/31651660
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/EDE.0000000000001132
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller